Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
Authors:
Open Access
- 1 February 2021
- Vol. 24 (2) , 102054
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Indian Council of Medical Research
This publication has 26 references indexed in Scilit:
- Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infectionBiochemical and Biophysical Research Communications, 2020
- Can we contain the COVID-19 outbreak with the same measures as for SARS?The Lancet Infectious Diseases, 2020
- Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and TransmissibilityClinical Infectious Diseases, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- Importation and Human-to-Human Transmission of a Novel Coronavirus in VietnamNew England Journal of Medicine, 2020
- Syrian Hamster as an Animal Model for the Study on Infectious DiseasesFrontiers in Immunology, 2019
- Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal ResponsesClinical and Vaccine Immunology, 2016
- Mucosal immunity and vaccinesNature Medicine, 2005
- Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian HamstersJournal of Virology, 2005
- Immunoglobulin G and Its Function in the Human Respiratory TractMayo Clinic Proceedings, 1988